Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, ...

One diet came out a clear winner in a 30-year study involving more than 105,000 men and women and eight diets, researchers ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty ...

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by JPMorgan Chase & Co. from a “neutral” rating to an ...

Cantor Fitzgerald said that while the firm “congratulates” Alnylam Pharmaceuticals (ALNY) on last week’s Amvuttra approval, with the stock ...

Shares of Charles River Laboratories International Inc. slipped 3.37% to $161.35 Tuesday, on what proved to be an all-around ...

Over the last 7 days, the United States market has risen by 1.8%, contributing to a 10% increase over the past year, with earnings projected to grow by 14% annually in the coming years. In this ...

The United States market has shown a positive trend, rising 1.8% over the last week and 10% over the past year, with earnings projected to grow by 14% annually. In this environment, identifying high ...

Maravai LifeSciences Holdings Inc (MRVI) is expected to report $-0.07 for 4Q. McCormick & Co Inc (MKC) is expected to report $0.64 for 1Q. Movado Group Inc (MOV) is expected to report $0.39 for 4Q.

Axsome stock tumbled Tuesday after Axsome Therapeutics issued mixed results for its drug, Sunosi, in ADHD treatment.

Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.